Please wait a minute...
文章检索
预防医学  2025, Vol. 37 Issue (3): 288-292,295    DOI: 10.19485/j.cnki.issn2096-5087.2025.03.016
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
高尿酸血症患者胫前动脉粥样硬化的影响因素分析
孙露, 郑东, 张洪超
达州市中西医结合医院,四川 达州 635000
Influencing factors for anterior tibial artery atherosclerosis among patients with hyperuricemia
SUN Lu, ZHENG Dong, ZHANG Hongchao
Dazhou Integrated TCM & Western Medicine Hospital, Dazhou, Sichuan 635000, China
全文: PDF(881 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解高尿酸血症患者胫前动脉粥样硬化的影响因素,为预防高尿酸血症患者胫前动脉粥样硬化提供参考。方法 选择2020—2023年在达州市中西医结合医院就诊的≥18岁高尿酸血症患者为研究对象,通过电子病历收集人口学信息和血生化指标等资料,采用彩色多普勒超声评估胫前动脉粥样硬化情况;采用多因素logistic回归模型分析高尿酸血症患者胫前动脉粥样硬化的影响因素。结果 调查高尿酸血症患者1 105例,其中男性862例,占78.01%;女性243例,占21.99%。年龄≥60岁918例,占83.08%。病程≥10年457例,占41.36%。血尿酸水平MQR)为480.79(98.28)μmol/L。高尿酸血症患者胫前动脉粥样硬化314例,占28.42%。多因素logistic回归分析结果显示,体质指数(≥24.0 kg/m2,OR=1.597,95%CI:1.185~2.151)、长期吸烟史(有,OR=1.709,95%CI:1.153~2.534)、糖尿病(有,OR=1.517,95%CI:1.162~1.981)、血尿酸(≥480.79 μmol/L,OR=1.667,95%CI:1.131~2.457)、血肌酐(≥97 μmol/L,OR=1.685,95%CI:1.155~2.460)、空腹血糖(≥6.1 mmol/L,OR=1.528,95%CI:1.106~2.112)、纤维蛋白原(>4 g/L,OR=1.589,95%CI:1.091~2.315)、三酰甘油(≥1.7 mmol/L,OR=1.879,95%CI:1.226~2.881)是高尿酸血症患者胫前动脉粥样硬化的影响因素。结论 高尿酸血症患者胫前动脉粥样硬化主要与长期吸烟、糖尿病和血尿酸、血肌酐、空腹血糖、纤维蛋白原、三酰甘油水平高有关。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
孙露
郑东
张洪超
关键词 高尿酸血症胫前动脉粥样硬化影响因素    
AbstractObjective To analyze the influencing factors for anterior tibial artery atherosclerosis among patients with hyperuricemia, so as to provide insights into the prevention of anterior tibial artery atherosclerosis. Methods Patients aged 18 years and older with hyperuricemia in Dazhou Integrated TCM & Western Medicine Hospital were enrolled as research subjects from 2020 to 2023. Demographic information and blood biochemistry indicators were collected through electronic medical records. Anterior tibial artery atherosclerosis was evaluated by color Doppler ultrasound. Factors affecting anterior tibial artery atherosclerosis among patients with hyperuricemia were analyzed by a multivariable logistic regression model. Results A total of 1 105 patients with hyperuricemia were surveyed, including 862 males (78.01%) and 243 females (21.99%). There were 918 cases (83.08%) at the ages of 60 years and older, and 457 cases (41.36%) with a course of disease at 10 years and longer. The median level of blood uric acid was 480.79 (interquartile range, 98.28) μmol/L. There were 314 cases (28.42%) with anterior tibial artery atherosclerosis. Multivariable logistic regression analysis showed that body mass index (≥24.0 kg/m2, OR=1.597, 95%CI: 1.185-2.151), long-term smoking history (yes, OR=1.709, 95%CI: 1.153-2.534), diabetes mellitus (yes, OR=1.517, 95%CI: 1.162-1.981), serum uric acid (≥480.79 μmol/L, OR=1.667, 95%CI: 1.131-2.457), serum creatinine (≥97 μmol/L, OR=1.685, 95%CI: 1.155-2.460), fasting blood glucose (≥6.1 mmol/L, OR=1.528, 95%CI: 1.106-2.112), fibrinogen (>4 g/L, OR=1.589, 95%CI: 1.091-2.315) and triglycerides (≥1.7 mmol/L, OR=1.879, 95%CI: 1.226-2.881) were influencing factors for anterior tibial artery atherosclerosis among patients with hyperuricemia. Conclusion Anterior tibial artery atherosclerosis among patients with hyperuricemia is associated with long-term smoking, diabetes mellitus, serum uric acid, serum creatinine, fasting blood glucose, fibrinogen and triglycerides high level.
Key wordshyperuricemia    anterior tibial artery atherosclerosis    influencing factor
收稿日期: 2024-08-22      修回日期: 2024-12-03      出版日期: 2025-03-10
中图分类号:  R587.2  
作者简介: 孙露,本科,主治医师,主要从事超声诊断工作
通信作者: 郑东,E-mail:253169126@qq.com   
引用本文:   
孙露, 郑东, 张洪超. 高尿酸血症患者胫前动脉粥样硬化的影响因素分析[J]. 预防医学, 2025, 37(3): 288-292,295.
SUN Lu, ZHENG Dong, ZHANG Hongchao. Influencing factors for anterior tibial artery atherosclerosis among patients with hyperuricemia. Preventive Medicine, 2025, 37(3): 288-292,295.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2025.03.016      或      http://www.zjyfyxzz.com/CN/Y2025/V37/I3/288
[1] 林淑芃. 《中国高尿酸血症与痛风诊疗指南(2019)》解读[J].临床内科杂志,2020,37(6):460-462.
LIN S F.Interpretation of the 2019 Chinese Guideline for the Diagnosis and Treatment of Hyperuricemia and Gout[J].J Clin Intern Med,2020,37(6):460-462.(in Chinese)
[2] KIMURA Y,TSUKUI D,KONO H.Uric acid in inflammation and the pathogenesis of atherosclerosis[J].Int J Mol Sci,2021,22(22):1-19.
[3] 周正雅,柴玉琼,袁晶,等.成人血尿酸水平与冠状动脉粥样硬化性心脏病的关联分析[J].公共卫生与预防医学,2023,34(1):141-143.
ZHOU Z Y,CHAI Y Q,YUAN J,et al.Relationship between uric acid and coronary atherosclerotic heart disease in adults[J].J Pub Health Prev Med,2023,34(1):141-143.(in Chinese)
[4] 徐东,殷婷,谢旭品,等.血尿酸联合单核细胞趋化因子1对下肢动脉硬化闭塞患者的诊断价值[J].心脑血管病防治,2020,20(6):622-624,628.
XU D,YIN T,XIE X P,et al.Diagnostic value of serum uric acid combined with monocyte chemotactic protein-1 in patients with lower extremity arterial occlusion[J].Cardio-Cerebrovasc Dis Prev Treat,2020,20(6):622-624,628.(in Chinese)
[5] 中华医学会内分泌学分会.中国高尿酸血症与痛风诊疗指南(2019)[J].中华内分泌代谢杂志,2020,36(1):1-13.
Chinese Society of Endocrinology,Chinese Medical Association.Guideline for the diagnosis and management of hyperuricemia and gout in China(2019)[J].Chin J Endocrinol Metab,2020,36(1):1-13.(in Chinese)
[6] HOMMA S,HIROSE N,ISHIDA H,et al.Carotid plaque and intima-media thickness assessed by b-mode ultrasonography in subjects ranging from young adults to centenarians[J].Stroke,2001,32(4):830-835.
[7] 冯可欣,郑启健,吕康,等.血脂及血尿酸对颈动脉粥样硬化发生风险的交互作用研究[J].中国脑血管病杂志,2022,19(10):667-676.
FENG K X,ZHENG Q J,LYU K,et al.Interaction of blood lipid and serum uric acid on the risk of carotid atherosclerosis[J].Chin J Cerebrovasc Dis,2022,19(10):667-676.(in Chinese)
[8] 方堃,丁岩,霍康.超重/肥胖与血浆致动脉粥样硬化指数及其交互作用对45岁及以上人群2型糖尿病患病风险的影响[J].郑州大学学报(医学版),2023,58(4):489-493.
FANG K,DING Y,HUO K.Interaction between overweight/obesity and atherogenic index of plasma on risk of type 2 diabetes mellitus for population with age ≥45 years[J].J Zhengzhou Univ(Med Sci),2023,58(4):489-493.(in Chinese)
[9] 杨烁,于波.吸烟与他汀类药物疗效在冠状动脉粥样硬化中的相互影响[J].心血管康复医学杂志,2021,30(3):366-370.
YANG S,YU B.Interaction between smoking and statins in coronary atherosclerosis[J].Chin J Cardiovasc Rehabil Med,2021,30(3):366-370.(in Chinese)
[10] 姚翡,郁秋荣,龚叶,等.2型糖尿病并发高尿酸血症患者血尿酸与粒淋比、γ-谷氨酰转肽酶的相关性及HUA发生的因素[J].河北医科大学学报,2022,43(10):1147-1152.
YAO F,YU Q R,GONG Y,et al.Correlation between serum uric acid,neutrophil-to-lymphocyte ratio and γ-glutamyl transpeptidase in patients with type 2 diabetes mellitus complicated with hyperuricemia and the influencing factors of hyperuricemia[J].J Hebei Med Univ,2022,43(10):1147-1152.(in Chinese)
[11] LEE T S,LU T M,CHEN C H,et al.Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway[J].Redox Biol,2021,46:1-9.
[12] 王少慧,刘鉴文,曾志伟.老年2型糖尿病合并高尿酸血症患者糖化血红蛋白、胱抑素C水平及其与血尿酸、血肌酐相关性分析[J].中国现代医药杂志,2021,23(2):73-75.
WANG S H,LIU J W,ZENG Z W.Correlation analysis of glycated hemoglobin,cystatin C levels,and their relationship with serum uric acid and serum creatinine in elderly patients with type 2 diabetes mellitus complicated by hyperuricemia[J].MMJC,2021,23(2):73-75.(in Chinese)
[13] 刘淑党,林静娜,邱慧娜,等.2型糖尿病患者血尿酸水平与发生动脉粥样硬化性心血管疾病事件风险的影响研究[J].中国糖尿病杂志,2022,30(4):241-245.
LIU S D,LIN J N,QIU H N,et al.Effect of serum uric acid level on the risk of ASCVD in patients with type 2 diabetes mellitus[J].Chin J Diabetes,2022,30(4):241-245.(in Chinese)
[14] 范为群,罗文良,邵布勒,等.直接胆红素和血脂对颈动脉粥样硬化及颈动脉斑块发生风险的交互作用[J].预防医学,2020,32(6):563-568.
FAN W Q,LUO W L,SHAO B L,et al.The interaction between direct bilirubin and blood lipids on carotid atherosclerosis and carotid plaque[J].China Prev Med J,2020,32(6):563-568.(in Chinese)
[1] 王晓闪, 叶丽香, 陈莉, 李敏香, 王心语, 蔡小霞. 基于潜在剖面分析的慢性病住院患者服药依从性影响因素分析[J]. 预防医学, 2025, 37(3): 217-222.
[2] 常恬悦, 王丽娟, 宋亮, 姜树林, 丁海峰, 高彦杰, 李欣格, 刘英杰. 男男性行为人群无保护肛交行为的影响因素分析[J]. 预防医学, 2025, 37(3): 233-237,242.
[3] 缪彩云, 覃玉, 万亚男, 陈路路, 崔岚, 王小莉. 江苏省居民自测血压行为及影响因素分析[J]. 预防医学, 2025, 37(3): 223-227.
[4] 牛金枝, 吴晓煜, 宁艳娇, 冯亚静, 单伟颖. 体外受精-胚胎移植反复种植失败影响因素的Meta分析[J]. 预防医学, 2025, 37(3): 237-242.
[5] 孙佳美, 卢巧玲, 高华强, 杨作凯, 徐来潮. 肺结核密切接触学生结核菌素皮肤试验结果分析[J]. 预防医学, 2025, 37(3): 243-247.
[6] 应慧珍, 吉丽, 孔文娟, 王媛, 陈晓霞, 胡彩虹, 傅海英, 卢园园, 车秀丽. 磐安县绝经女性绝经综合征调查[J]. 预防医学, 2025, 37(3): 312-315.
[7] 由娜, 梁小娴, 赖春燕, 阮慧红. 番禺区女性乳腺癌患者生存分析[J]. 预防医学, 2025, 37(3): 321-324.
[8] 王苓, 许珂, 张兴亮, 黄思超, 李西婷, 陈珺芳. 2022年杭州市新报告HIV/AIDS病例感染特征分析[J]. 预防医学, 2025, 37(2): 123-129.
[9] 陈溪, 杨泓生, 李炜, 翟睿, 姜妍琳, 王俊宏. 中国儿童孤独症谱系障碍影响因素的Meta分析[J]. 预防医学, 2025, 37(2): 181-188.
[10] 陈剑双, 朱礼明, 乐博昕, 王成义, 刘效峰, 何凡. 宝山区吸毒人群丙型肝炎病毒感染状况调查[J]. 预防医学, 2025, 37(2): 168-172.
[11] 米孝濛, 熊苏婷, 徐文国, 徐文超. 常州市35岁及以上居民血脂异常调查[J]. 预防医学, 2025, 37(2): 173-177.
[12] 吴亚琼, 房新柱. 西安市在校大学生健康素养水平分析[J]. 预防医学, 2025, 37(2): 197-200.
[13] 黄健玲, 曾静, 罗锐, 顾菁. 职业高中学生电子烟使用及尝试意愿调查[J]. 预防医学, 2025, 37(2): 201-207.
[14] 见明智, 鲁迪, 蒋婷婷, 陈洁. 中学生电子烟尝试使用的影响因素分析[J]. 预防医学, 2025, 37(2): 208-211,216.
[15] 韩丹, 赵娅, 黄恩善, 叶树花, 汪万进, 吴方敏, 王定良, 章荣华. 生物活性肽联合益生菌干预对高尿酸血症患者血尿酸水平的影响[J]. 预防医学, 2025, 37(1): 40-45.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed